drugset / Trial / NCT05893797
A Study of LY8888AX in Participants Using a Connected Insulin Management Platform
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to assess participant adherence and glucose control while using a connected insulin management platform. Approximately 50 participants will be enrolled in each country.
Timeline
- Start
- 2023-10-05
- Primary completion
- 2024-09-16
- Completion
- 2024-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Insulin Lispro | Protein / enzyme biologic | — | — |